Anibal Salazar

Santiago, RM, Chile

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study.

Patient-reported Outcomes for Men with Metastatic Castration-resistant Prostate Cancer Who Received Olaparib plus Abiraterone Versus Placebo plus Abiraterone in the Phase 3 PROpel Study.

Journal: European urology oncology

Published: March 28, 2025

Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.

Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.

Journal: European urology oncology

Published: December 18, 2023

The CAPRA-S Score and Immune Dysfunction as a Guide to Outcome in Men Treated with Prostatectomy Radical as Mono-Therapy for Prostate Cancer.

The CAPRA-S Score and Immune Dysfunction as a Guide to Outcome in Men Treated with Prostatectomy Radical as Mono-Therapy for Prostate Cancer.

Journal: Archivos espanoles de urologia

Published: September 22, 2022

Increasing Immune Dysfunction is Associated with Increasing Matrix-Metalloproteinase-2 Expression and Predicts Biochemical Failure in Men with Bone Marrow Micro-Metastasis Positive Localized Prostate Cancer.

Increasing Immune Dysfunction is Associated with Increasing Matrix-Metalloproteinase-2 Expression and Predicts Biochemical Failure in Men with Bone Marrow Micro-Metastasis Positive Localized Prostate Cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: April 05, 2022

Atypical presentation of COVID-19: Chronic bilateral testicular pain with lower extremity peripheral polyneuropathy, case report.

Atypical presentation of COVID-19: Chronic bilateral testicular pain with lower extremity peripheral polyneuropathy, case report.

Journal: Urology case reports

Published: October 18, 2021

CAPRA score vs minimal residual disease as predictors of biochemical recurrence after radical prostatectomy.

CAPRA score vs minimal residual disease as predictors of biochemical recurrence after radical prostatectomy.

Journal: Archivos espanoles de urologia

Published: July 05, 2021

Renal infarction associated with asymptomatic Covid-19 infection.

Renal infarction associated with asymptomatic Covid-19 infection.

Journal: Hematology, transfusion and cell therapy

Published: January 04, 2021

The Epstein criteria predict for organ-confined prostate cancer but not for minimal residual disease and outcome after radical prostatectomy.

The Epstein criteria predict for organ-confined prostate cancer but not for minimal residual disease and outcome after radical prostatectomy.

Journal: Turkish journal of urology

Published: April 25, 2020

The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy.

The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy.

Journal: Ecancermedicalscience

Published: April 16, 2020

The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy.

The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy.

Journal: Ecancermedicalscience

Published: February 20, 2020

Circulating prostate cells and bone marrow micro-metastasis and not treatment modality determine the risk and time to biochemical failure in low risk prostate cancer.

Circulating prostate cells and bone marrow micro-metastasis and not treatment modality determine the risk and time to biochemical failure in low risk prostate cancer.

Journal: Archivos espanoles de urologia

Published: December 12, 2019

The expression of matrix-metalloproteinase-2 in bone marrow micro-metastasis is associated with the presence of circulating prostate cells and a worse prognosis in men treated with radical prostatectomy for prostate cancer.

The expression of matrix-metalloproteinase-2 in bone marrow micro-metastasis is associated with the presence of circulating prostate cells and a worse prognosis in men treated with radical prostatectomy for prostate cancer.

Journal: Turkish journal of urology

Published: November 09, 2019

Showing 1-12 of 20

Last Updated: 09/26/2026